ArriVent BioPharma logo
ArriVent BioPharma
AVBP | NASDAQ
Chart Builder DCF Calculator
$11.56
-$1.45 (-11.15%)
At close: Nov 16, 2026, 4:00 PM ET
$11.56
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

ArriVent BioPharma Income Statement

Income statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
– – – – –
– – – – –
– – – – –
-177.53M -94.31M -74.59M -36.91M -8.7M
11.23M 13.82M 5.26M – –
-166.31M -80.49M -69.33M -36.91M -51.61M
-166.31M -80.49M -69.33M -36.91M -51.61M
24.18M 15.3M 9.71M 6.47M 2.26M
153.35M 79M 64.88M 30.43M 6.43M
– – – – –
177.53M 94.31M 74.59M 36.91M 8.7M
– – – – –
– – – – –
177.53M 94.31M 74.59M 36.91M 8.7M
– – – – –
38.46M 31.47M 31.96M 33.49M 1.28M
38.46M 31.47M 31.96M 33.49M 1.28M
-4.32 -2.56 -2.17 -1.10 -40.44
-4.32 -2.56 -2.17 -1.10 -40.44
-166.31M -80.49M -69.33M – -51.61M
-166.31M -80.49M -69.33M -36.91M -51.61M
– – – 36.91M –

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.